| Nursing Care Services, Inc | |
| 7328 Lakeworth Rd, Greenacres, Florida 33467 | |
| (561) 433-1991 | |
| Name | Nursing Care Services, Inc |
|---|---|
| Location | 7328 Lakeworth Rd, Greenacres, Florida |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Medical Social Services Home Health Aide |
| Medicare ID | 109412 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 33403, 33407, 33408, 33460, 33463 |
| NPI Number | 1083867030 |
| Organization Name | NURSING CARE SERVICES, INC. |
| Address | 5700 Lake Worth Rd, Ste. 306, Greenacres, FL 33463 |
| Phone Number | 561-433-1991 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
| NPI Number | 1366497869 |
| Organization Name | HEALTH CARE AND RETIREMENT CORPORATION OF AMERICA |
| Doing Business As | HEARTLAND HOME HEALTH CARE |
| Address | 5700 Lake Worth Rd, Suite 100, Greenacres, FL 33463 |
| Phone Number | 561-434-6515 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
| NPI Number | 1558502070 |
| Organization Name | QUALITY NURSING HOME HEALTH, LLC |
| Address | 5700 Lake Worth Rd, Suite 311-6, Greenacres, FL 33463 |
| Phone Number | 561-734-0014 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
| NPI Number | 1568147890 |
| Organization Name | NURSING CARE SERVICES, INC. |
| Address | 5350 10th Ave N Ste 8, Greenacres, FL 33463 |
| Phone Number | 561-433-1991 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
| Quality Rating: |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 82.4 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.3 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 92.6 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 100 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 70.1 | 79.6 |
| How often patients got better at getting in and out of bed | 75.2 | 81.1 |
| How often patients got better at bathing | 89.5 | 82.3 |
| How often patients’ breathing improved | 100 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 100 | 75 |
| How often home health patients had to be admitted to the hospital | 16.5 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 9.8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 100 | 94 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
The patient survey data of Nursing Care Services, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 48 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 44 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 21 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 65 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 65 | 78 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
› Verified 5 days ago
Striving For Excellence Home Health Care Inc Location: 5199 10th Ave N Ste 110, Greenacres, Florida 33463 Ratings: Phone: (561) 968-7025 | |
Twentyfour Seven Home Health Care Inc Location: 6801 Lake Worth Rd Ste 126, Greenacres, Florida 33467 Ratings: NA Phone: (561) 963-6400 | |
Nursing Care Services, Inc Location: 7328 Lakeworth Rd, Greenacres, Florida 33467 Ratings: Phone: (561) 433-1991 | |
Absolute Caregivers Home Health Agency Inc Location: 4000 S 57th Ave Ste 203, Greenacres, Florida 33463 Ratings: Phone: (561) 844-7196 | |
All Health Care Services Inc Location: 6801 Lake Worth Rd Ste 219, Greenacres, Florida 33467 Ratings: Phone: (561) 487-0553 | |
Genoma Home Health Care Agency Inc Location: 4621 Lake Worth Rd, Greenacres, Florida 33463 Ratings: NA Phone: (561) 410-5622 |